chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Covered with red bumps that have a crust in the middle/got the bump/creeping up to the chest; Psoriasis; Lichen plantus; Covered with red bumps that have a crust in the middle; Rash/Couple of spots on the leg; This spontaneous case was reported by a patient and describes the occurrence of MASS (Covered with red bumps that have a crust in the middle/got the bump/creeping up to the chest), PSORIASIS (Psoriasis), LICHEN PLANUS (Lichen plantus), ERYTHEMA (Covered with red bumps that have a crust in the middle) and RASH (Rash/Couple of spots on the leg) in a 65-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 053022A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high, Osteoarthritis, Type 2 diabetes mellitus and Hypercholesterolemia.    On 06-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 10-Oct-2022, the patient experienced RASH (Rash/Couple of spots on the leg). On an unknown date, the patient experienced MASS (Covered with red bumps that have a crust in the middle/got the bump/creeping up to the chest), PSORIASIS (Psoriasis), LICHEN PLANUS (Lichen plantus) and ERYTHEMA (Covered with red bumps that have a crust in the middle). The patient was treated with FLUOCINONIDE at a dose of 0.05 percent ointment twice a day. At the time of the report, MASS (Covered with red bumps that have a crust in the middle/got the bump/creeping up to the chest), PSORIASIS (Psoriasis), LICHEN PLANUS (Lichen plantus), ERYTHEMA (Covered with red bumps that have a crust in the middle) and RASH (Rash/Couple of spots on the leg) had not resolved.            No concomitant medications were reported. On 25-Mar-2021, the patient received first dose of Moderna COVID-19 vaccine of batch number 026A21A. On 24-Apr-2021, the patient received second dose of Moderna COVID-19 vaccine of batch number 008B212A. On 28-Oct-2021, the patient received first booster dose (dose 3) of Moderna COVID-19 vaccine of batch number 011A21A. Patient did not had COVID positive test or diagnosis Treatment information included patient was instructed to use ointment for two weeks, stop for a week, and start it again. It was reported that patient was only using ointment because doctors had prescribed it but it was not doing anything.   This case was linked to MOD-2022-681960 (Patient Link).
Wrong 2nd dose COVID Vaccine was administered. Nurse on site inadvertently administered Pfizer 0.3 ml IM as 2nd dose However, patient should have received Moderna 0.5 ml IM as 2nd dose Nurse reported error immediately to patient and supervisor , assessed patient for change in VS and any s/sx  indicating reaction. Assessed patient for more than 30 minutes with no negative reaction noted.  Patient advised  regarding VAERS reporting in case symptoms occur at a later point.
On 1/21/21, approximately 59 hours after I received the Pfizer\BioNTech COVID19 Vaccine #2 without any immediate adverse events, I woke up in the middle of the night with subjective fevers, sweats, chills,  generalized weakness with dizziness and feeling faint, nausea, diarrhea, and severe pelvic/lower abdominal pain (though I was also in the process of starting my menstrual cycle).  I also vaguely noticed an erythematous rash on my chest and abdomen at that time.  I took a dose of ondansetron for nausea and acetaminophen for pain.  Later that morning (1/21/21), I continued to have generalized weakness, subjective fevers and chills, extreme fatigue, nausea, and a morbilliform-type rash most prominently on my torso (chest, abdomen, back) and some areas of my upper arms and thighs, as well as bright red and hyperemic palms and soles that had a prickly sensation throughout.  I no longer had abdominal pain, but did have significant polyarthritis with difficulty moving my joints without pain.  This included my knees, elbows, ankles, wrists, as well as fingers/hands especially.  My fingers and toes felt very swollen and I had trouble putting my normal enclosed shoes on.  I took ibuprofen and Tylenol during this time for symptom control.  Later I added diphenhydramine, loratadine, and famotidine.  These symptoms waxed and waned in intensity for at least 8 days with continued spread of rash, extreme fatigue, ongoing joint pain, and subjective fevers.  The only measured fever was on 1/23/21 when I had access to a thermometer - my oral temperature was 100.7F if I recall correctly.  I never had any respiratory symptoms. On 1/29/21 I saw Hospital Allergist Dr in order to participate in a research study on adverse vaccine reactions; I did not have a formally documented medical appointment with her for my medical records.  By that time, my energy level was slowly improving and I was able to return to work.  My arthritis symptoms had nearly fully resolved, however, my rash had gone from not particularly bothersome to very diffusely pruritic.  I began to take cetirizine for symptoms instead of loratidine. In addition, the skin along my L palm began to slough and peel off, most notably in the webspaces between my thumb and index finger bilaterally and the tip of my L thumb and L ring finger.  These areas of my palm had the most notable peeling and sloughing around 2/2/21 and by 2/7/21 my R palm was also peeling in similar fashion to the L.  On 2/11/21, I noticed that the skin along my L sole, particularly between all five digits had begun to peel quite markedly; large connected pieces of skin were sloughing off.  The sloughing on the L foot spread from between the toes and the ball of the foot to the arch and then the heel over several days.  On 2/14/21, the R foot/sole began having the same findings, with large amounts of sloughing first between the toes and then extending to the ball of the foot, arch, and ultimately the heel.  Some sort of foot/sole peeling continued through the final week of February 2021 and into early March.
Fever 101, severe aches, swelling of face, fast heartbeat, bad rash all over body, dizziness and weakness, headache
A nurse reported that a female pt received an injection of flu shield on 11/15/2001. At the time of immunization, the pt developed pain at the injection site which radiated to her fingertips. Later that same day, the pt developed nausea, vomiting, and her arm ached. On 11/016/2001, she developed a rash on her back. Her symptoms resolved in 48 hours. This is 1 of 4 pts who had an adverse experience following receipt of flu shield.
flu-like reaction; temperature; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like reaction) and PYREXIA (temperature) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like reaction) and PYREXIA (temperature). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (flu-like reaction) and PYREXIA (temperature) had resolved.            Concomitant medications were not reported.  On 29-Feb-2021, the patient received 1st dose of Moderna.  It was reported that after each of Moderna doses patient had a flu-like reaction with a temperature in the evening. This went away after 48-72 hours.   This case was linked to MOD-2022-650917 (Patient Link).
High fever (104), vomiting entire night. Twitching (unsure if seizure) while temperature was high.
Patient has been fully vaccinated as of 2/4/21. Patient has tested positive as of 8/14/21
This spontaneous report as received from a medical assistant reports that some unspecified patients on an unspecified date may have received an adult dose of 1 ml of VAQTA (lot number H010269, expiration date 03-NOV-2014) (dose, frequency and route not reported) that from 22-MAR-2013 to 26-MAR-2013 some vials of VAQTA had been exposed to 9 degrees Celsius for 96 hours and had developed a filmlike coating inside the vial. The medical assistant reported that some vials were clear, with cloudy sediment that resuspends, and that others were essentially clear, with the same resuspending sediment, but also appeared to be coated with a film-like substance. The solution was reported to be clear, and maybe thinner than expected. No adverse effects reported. A product quality complaint has been filed for appearance change of vaccine. This case is linked to MARRS # 1303USA013510, 1304USA000421, 1304USA001054. Additional information has been requested.
urinary tract infection; This spontaneous case was reported by an other health care professional and describes the occurrence of URINARY TRACT INFECTION (urinary tract infection) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B218) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URINARY TRACT INFECTION (urinary tract infection). At the time of the report, URINARY TRACT INFECTION (urinary tract infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Treatment information was not provided by the reporter.   This case was linked to MOD-2021-272959 (Patient Link).
Received Tetanus injection on 07/11/05, complained of pain in right deltoid that started on 07/13/05, complained of pain still in right deltoid moving up into shoulder 07/21/05. As of 08/04/05 doctor did not received any additional complaints from the patient.
Did not experience anything within the first 24 hrs. The next day she started to have dizziness. She got to the point where she couldn't hold her balance. When she make sudden movements she become dizzy. She stated it comes randomly.
Intense skin hypersensitivity over most of my body. Like having a bad all-over sunburn.  Chills, fatigue, and minor aches and joint pain
QUARTER SIZE 6-8 INCHES REDNESS AROUND THE CENTER OF CHEST HEART AREA; FLUSHED CHEST; BLOTCHY CHEST AND AROUND NECK; FELT A LITTLE UNDER THE WEATHER; This spontaneous report received from a patient concerned a 30 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: non-alcohol user, non-smoker, grass allergy, and animal allergy, and other pre-existing medical conditions included: The patient had no medical issues and had no history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822809, and expiry: UNKNOWN) dose was not reported, administered on 18-OCT-2021 for prophylactic vaccination.  No concomitant medications were reported.  On 19-OCT-2021, the patient experienced felt a little under the weather.  On 20-OCT-2021, the patient experienced quarter size 6-8 inches redness around the center of chest heart area. On 20-OCT-2021, the patient experienced flushed chest. On 20-OCT-2021, the patient experienced blotchy chest and around neck. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from felt a little under the weather, and the outcome of quarter size 6-8 inches redness around the center of chest heart area, blotchy chest and around neck and flushed chest was not reported. This report was non-serious.
injection site pain, headache , chills, muscle pain, joint pain, fever(2/2/21  7:00 am 99.7F, 5.00pm 100.9 F, 7:30 pm 101.5 F) ,general unwell feeling
This spontaneous report was received from a physician via a company representative, referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 27-MAR-2015, the patient was vaccinated with an improperly stored dose of ROTATEQ 2ml, 10 unit dose tube, lot # J010140; expiration date 26-APR-2016 (dose and dose number were not reported). There were no concomitant medications provided. No adverse effects reported. No product quality complaint was involved. On an unspecified dates, the ROTATEQ had 5 temperatures excursions of 24, 80, 1172, 336 and 200 hours. The lowest recorded temperature was -3 Celsius and the highest recorded temperature was 59F (15 Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator (R)". This is one of several cases from the same reporter. Additional information has been requested.
I woke up at 4 am to pump breastmilk. I experienced chills, achy muscles and night sweats up to that point. After pumping, I became extremely light headed with muffled hearing, black vision spots, and proceeded to collapse.  I was momentarily confused. I lied down in bed with my feet elevated and experienced ringing in the ears and headache. After 10 minutes, my symptoms had improved, with chills and sweating remaining. By morning, all symptoms had resolved.
patient  provided a immunization record with one dose of shingrix recorded. She states that she needed second dose. AFter the vaccine was administered and recorded it was noted in her chart that she had already received 2 doses. She states that she does not recall receiving second dose although it was administered. She states that she feel well, no adverse effects noted at this time.
Arrived with SOB. Admit for COVID pna. Fully vaccinated. Treated with O2, duonebs, doxy, lovenox, steroids, zinc, singulair, Ivermectin, plasma, remdesivir. Initially looked to improve and was back to baseline 3L O2, but then developed hypotension and rapidly declined; septic shock 2/2 HCAP. Transitioned to comfort care and expired.
Shingles broke out at 4:30 pm 11/08/08. Rash or blister like over left eye- on forehead + into scalp + hair. Not to painful but very uncomfortable especially at night. Have had many sleepless nights. Doctor prescribed some pills - for - 6 days at outset - then said its going to take its course.
After mild redness and swelling at injection site for a day or two after the vaccination, the arm issue cleared up. 8 days later, the arm became even more red and swollen and hot to the touch. This is only day two of this delayed reaction, so not sure how long it will last. A simple Google reveals a lot of people having the same issue.
covid vaccine breakthrough   dose 1 Pfizer 3/9/21 EN6208 dose 2 Pfizer 3/30/21 EW0150
Rashes on left arm, not on shot site, Rashes on right leg and arm Increase in neuropathy and arthritis pain
Tinnitus in right ear, beginning nine days after second Pfizer shot. Severity increases in the presence of loud environmental noise.
Pt received a PNEUMOVAX on 2/17/09 and noted a reaction on 2/18/09 arm swollen (raised) 7x7 red area with a small fine rash, Hot to touch and painful.
Approximately 5 minutes after receiving vaccines, experienced rash on bilateral legs at injection sites. Moderate amount of redness at bilat legs at injection sites. Small amount of redness and rash at abdomen and back. No resp distress. MD ordered 5cc Benadryl Po. Rash and redness improved with slight redness at injection sites. Pt discharged at approx 1105 with instructions to continue Benadryl Q 6hrs.
Within 15 min of the injection. I had a few welt hives on the right fore arm. Tingling in the face, lips, arms, After 30 minutes same feelings, drank water.  After 30 -45 minutes noticed two nodule circular rosea type under the skin in the left arm. and now face, and lips still tingling , Left arm a little tight.  More welt-type hives on the right arm so took benadryl. Lips tight and forehead itching and back. Drank more water. At home , applied cold towels to injection site and welt hives. Took cool shower and more benadryl and water. Went to pharmacy to ask if anything else will help. WIthin 12-16 hours drank 32 ounces of water and 3 teaspoons of benadryl..Between 16-24 hours taking another 2 teaspoons of benaryl and 32 to 64 ounces of water and trued range of motion exercies due to stiffness of joints and tightness of hands, back, neck, arms adn joints.
At 17:00, the injection site started to itch and was warm to the touch. At 4:00 on 01/04/2021, I experienced extreme vertigo while washing my hands at a sink. I returned to bed to get the vertigo to pass, but then vomited at 4:30. I was extremely tired the remainder of the day, sleeping often and have been flushed all day as well.
After vaccine arm became red and swollen at site and upper arm. Pt. developed fever 102.4 next day. Developed H/A, body aches, SOB and on and off fever over next 10-11 days. (Redness/swelling subsided after 4 days). Pt. still with body aches, dizziness. Temp 101.
Symptoms: vomiting, fever, body aches, fever, sweats, scratchy throat , injection site numb down to elbow
Upon first receiving the vaccine within about 15 minutes i felt very dizzy, this lasted about a half hour. i was released to leave at about 12:50 after sitting in a waiting room at Pharmacy, city state location which is where i received my vaccine.  After leaving i again felt very dizzy almost as if i couldn't walk straight. Within the first 24 hours of having the vaccine i developed severe muscle cramps and fatigue, along with a pretty bad headache. I then developed a very itchy and red rash on my neck and chest that lasted about a day. I had extreme fatigue following this vaccine and still have extreme fatigue today, which is 6 days after the vaccination.
during evening p/vax pt devel severe abdo pain-seen by MD 4AUg93; pt stated was told elevated temp, elevated WBC; abdo ultrasound (neg); had no local site react;
Caused abnormal extra painful and high volume period off cycle, about 10 days after just having a period
I was achy took Tylenol that relieved it. Got chest pains and heart palpitations that came and went. Face is also puffy and fatigue. Went to ER.
I have no history of blood clots. I have not been infected with COVID-19. I received the first dose of the J&J vaccine on January 5, 2022. I felt a cramping pain in right calf around January 9, 2022. The pain grew progressively worse and i went to Urgent care on January 22, 2022. On January 31, 2022 I could barely walk so i called my PCP and they recommended going to urgent care. On February 1, 2022 I went to a local Hospital emergency department. Ultrasound identified DVT in right calf. The ER Doctor sent me home with a prescription for Xarelto. On February 2, 2022 I woke up and had difficulty breathing. I did telemedicine appointment at 9:00 am and was told to go back to the emergency room. CT indicated bilateral pulmonary embolism. I was admitted to the hospital and treated until 2/4/2022 when I was discharged and sent home to continue treating with xarelto.
Information has been received from a registered nurse (R.N.) concerning an 18 year old female patient with asthma and no drug reactions/allergies who on 25-JUN-2010 was vaccinated IM with 0.5 ML dose of GARDASIL (lot # 0318Z). There was no concomitant medication. In approximately 26-JUN-2010 (reported as "one or two days after vaccination") the patient experienced generalized rash. The generalized rash had disappeared but when she touched something cold such as ocean water or cold soda, her hand began to tingle and turned red. The patient sought unspecified medical attention and no laboratory diagnostic study was performed. At the time of reporting, the patient was recovering. Additional information has been requested.
Blacked out in washroom morning after injections (No history of ever blacking out before). Body very achey when awakened.
Pt has red, raised, warm area of 80mm X 60mm. Pt advised to take Benadryl at home & monitor breathing. If breathing difficulties arise call EMS or physician.
This spontaneous report was received from a registered nurse via medical assistant and refers to a 13-month-old male patient. The patient's pertinent medical history, concurrent conditions, concomitant medications, past drugs and drug allergies were not reported. On 28-SEP-2017, the patient was vaccinated with improperly stored M-M-R II (lot # M034387; expiry date: 19-JUL-2018) (dosing details were not provided) for prophylaxis. Temperature excursion details of the vaccine were not provided. This is one of the several reports received from the same source. Sender's Comments: US-009507513-1709USA008861: US-009507513-1710USA013424: US-009507513-1710USA013470: US-009507513-1710USA013465: US-009507513-1710USA013440: US-009507513-1710USA013468: US-009507513-1710USA013442: US-009507513-1710USA013445: US-009507513-1710USA013460: US-009507513-1710USA013463: US-009507513-1710USA013464: US-009507513-1710USA013438: US-009507513-1710USA013439: US-009507513-1710USA013450: US-009507513-1710USA013430: US-009507513-1710USA013469: US-009507513-1710USA013467: US-009507513-1710USA013435: US-009507513-1710USA013434: US-009507513-1710USA013432: US-009507513-1710USA013428: US-009507513-1710USA013437: US-009507513-1710USA013441: US-009507513-1710USA013443: US-009507513-1710USA013444: US-009507513-1710USA013446: US-009507513-1710USA013447: US-009507513-1710USA013448: US-009507513-1710USA013436: US-009507513-1710USA013449: US-009507513-1710USA013451: US-009507513-1710USA013452: US-009507513-1710USA013454: US-009507513-1710USA013455: US-009507513-1710USA013456: US-009507513-1710USA013457: US-009507513-1710USA013458: US-009507513-1710USA013459: US-009507513-1710USA013461: US-009507513-1710USA013462: US-009507513-1710USA013466: US-009507513-1710USA013427: US-009507513-1710USA013471: US-009507513-1710USA013472: US-009507513-1710USA013473: US-009507513-1710USA013474: US-009507513-1710USA013475: US-009507513-1710USA013476: US-009507513-1710USA013425: US-009507513-1710USA013433: US-009507513-1710USA013423: US-009507513-1710USA013040: US-009507513-1710USA013426: US-009507513-1710USA013429: US-009507513-1710USA013431: US-009507513-1709USA008666: Original Case: 1709USA008666: US-009507513-1710USA014650: Original Case: 1710USA014649: US-009507513-1710USA014651: Original Case: 1710USA014649: US-009507513-1710USA014649: Original Case: 1710USA014649.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site discomfort in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, immediately after receiving SHINGRIX, the patient experienced injection site discomfort. On an unknown date, the outcome of the injection site discomfort was unknown. It was unknown if the reporter considered the injection site discomfort to be related to SHINGRIX. Additional details reported as follows: The age at vaccination was not applicable for this report. The age group was not reported but was selected as adult as per vaccine indication. The healthcare professional reported that a lot of her patients had been complaining about feeling the vaccine going into the muscle when administering the vaccine.
Patient developed ITP after receiving the covid-19 vaccination.  He was admitted at the outside hospital in January 2021 and was found with a platelet level of 79.  He presented in this admission at hospital his platelets dropped to 30.
Lymphadenopathy- left anterior cervical chain, left supraclavicular, left  postauricular, left axillary. no other symptoms